Artwork

内容由How Women Lead提供。所有播客内容(包括剧集、图形和播客描述)均由 How Women Lead 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Revolutionizing Medicine with Cell-Based Therapies with Crystal Nyitray

21:08
 
分享
 

Manage episode 406167546 series 3312378
内容由How Women Lead提供。所有播客内容(包括剧集、图形和播客描述)均由 How Women Lead 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Every day, we see technology improving the systems and industries all around us. From finance to environmental science and more, technological advances are allowing us to make great changes to the way we live and work. The medical field is no exception, with scientists and inventors working tirelessly to improve healthcare across the board. Crystal Nyitray, the CEO of Encellin, is here today to talk about how her company is changing the game by introducing cell-based therapies, allowing healthcare to become even more personal. This week’s episode 107 of How Women Inspire Podcast is about revolutionizing medicine with cell-based therapies!

In this episode of How Women Inspire Podcast, Crystal Nyitray is sharing the importance of disruptive technology to improve our lives and actionable steps you can take right now to get involved with Encellin.
Crystal Nyitray is the Founder and CEO of Encellin. She is an alumna of UCSF, Sanofi, and Y Combinator. She led Encellin’s over $5M seed raise, authored over 10 patents, and is an awardee of MedTech Innovator, Rosenman Innovators, and American Diabetes Innovator.

Some of the talking points Julie and Crystal go over in this episode include:

  • The potential of encapsulated cell replacement therapy to revolutionize medicine.
  • How startups have the luxury of risk and can experiment with emerging technologies to benefit everyone.
  • Embracing inexperience as a strength and building networks from scratch.
  • How being comfortable with being different can lead to disruptive innovation and impactful change.

Thank you for listening! If you enjoyed this episode, take a screenshot of the episode to post in your stories and tag me! And don’t forget to follow, rate, and review the podcast and tell me your key takeaways!

Learn more about How Women Inspire at https://www.howwomenlead.com/podcast

CONNECT WITH CRYSTAL NYITRAY:

LinkedIn

Encellin
CONNECT WITH JULIE CASTRO ABRAMS:

LinkedIn - Julie

How Women Lead

How Women Invest

How Women Give

Instagram - HWL

LinkedIn - HWL

Facebook - HWL

  continue reading

章节

1. Revolutionizing Medicine with Cell-Based Therapies with Crystal Nyitray (00:00:00)

2. Crystal introduces her novel type one diabetes cell encapsulation device. (00:00:51)

3. The potential of encapsulated cell replacement therapy to revolutionize medicine. (00:04:26)

4. The value of unique perspectives provided by diverse voices. (00:09:36)

5. Embracing inexperience as a strength. (00:13:38)

6. The importance of sharing the vision with the community. (00:15:53)

7. Encouraging young women to pursue their passions. (00:18:13)

119集单集

Artwork
icon分享
 
Manage episode 406167546 series 3312378
内容由How Women Lead提供。所有播客内容(包括剧集、图形和播客描述)均由 How Women Lead 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Every day, we see technology improving the systems and industries all around us. From finance to environmental science and more, technological advances are allowing us to make great changes to the way we live and work. The medical field is no exception, with scientists and inventors working tirelessly to improve healthcare across the board. Crystal Nyitray, the CEO of Encellin, is here today to talk about how her company is changing the game by introducing cell-based therapies, allowing healthcare to become even more personal. This week’s episode 107 of How Women Inspire Podcast is about revolutionizing medicine with cell-based therapies!

In this episode of How Women Inspire Podcast, Crystal Nyitray is sharing the importance of disruptive technology to improve our lives and actionable steps you can take right now to get involved with Encellin.
Crystal Nyitray is the Founder and CEO of Encellin. She is an alumna of UCSF, Sanofi, and Y Combinator. She led Encellin’s over $5M seed raise, authored over 10 patents, and is an awardee of MedTech Innovator, Rosenman Innovators, and American Diabetes Innovator.

Some of the talking points Julie and Crystal go over in this episode include:

  • The potential of encapsulated cell replacement therapy to revolutionize medicine.
  • How startups have the luxury of risk and can experiment with emerging technologies to benefit everyone.
  • Embracing inexperience as a strength and building networks from scratch.
  • How being comfortable with being different can lead to disruptive innovation and impactful change.

Thank you for listening! If you enjoyed this episode, take a screenshot of the episode to post in your stories and tag me! And don’t forget to follow, rate, and review the podcast and tell me your key takeaways!

Learn more about How Women Inspire at https://www.howwomenlead.com/podcast

CONNECT WITH CRYSTAL NYITRAY:

LinkedIn

Encellin
CONNECT WITH JULIE CASTRO ABRAMS:

LinkedIn - Julie

How Women Lead

How Women Invest

How Women Give

Instagram - HWL

LinkedIn - HWL

Facebook - HWL

  continue reading

章节

1. Revolutionizing Medicine with Cell-Based Therapies with Crystal Nyitray (00:00:00)

2. Crystal introduces her novel type one diabetes cell encapsulation device. (00:00:51)

3. The potential of encapsulated cell replacement therapy to revolutionize medicine. (00:04:26)

4. The value of unique perspectives provided by diverse voices. (00:09:36)

5. Embracing inexperience as a strength. (00:13:38)

6. The importance of sharing the vision with the community. (00:15:53)

7. Encouraging young women to pursue their passions. (00:18:13)

119集单集

Toate episoadele

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南